GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » PB Ratio

Andros Pharmaceuticals Co (ROCO:6917) PB Ratio : 1.99 (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Andros Pharmaceuticals Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Andros Pharmaceuticals Co's share price is NT$20.95. Andros Pharmaceuticals Co's Book Value per Share for the quarter that ended in Dec. 2023 was NT$10.52. Hence, Andros Pharmaceuticals Co's PB Ratio of today is 1.99.

Good Sign:

Andros Pharmaceuticals Co Ltd stock PB Ratio (=1.99) is close to 2-year low of 1.91

The historical rank and industry rank for Andros Pharmaceuticals Co's PB Ratio or its related term are showing as below:

ROCO:6917' s PB Ratio Range Over the Past 10 Years
Min: 1.91   Med: 3.6   Max: 5.08
Current: 1.99

During the past 5 years, Andros Pharmaceuticals Co's highest PB Ratio was 5.08. The lowest was 1.91. And the median was 3.60.

ROCO:6917's PB Ratio is ranked better than
60.34% of 1311 companies
in the Biotechnology industry
Industry Median: 2.55 vs ROCO:6917: 1.99

During the past 12 months, Andros Pharmaceuticals Co's average Book Value Per Share Growth Rate was 38.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 46.40% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Andros Pharmaceuticals Co was 46.40% per year. The lowest was 16.60% per year. And the median was 31.50% per year.

Back to Basics: PB Ratio


Andros Pharmaceuticals Co PB Ratio Historical Data

The historical data trend for Andros Pharmaceuticals Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Andros Pharmaceuticals Co PB Ratio Chart

Andros Pharmaceuticals Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
- - - - 2.37

Andros Pharmaceuticals Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial - - - 5.22 2.37

Competitive Comparison of Andros Pharmaceuticals Co's PB Ratio

For the Biotechnology subindustry, Andros Pharmaceuticals Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Andros Pharmaceuticals Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Andros Pharmaceuticals Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Andros Pharmaceuticals Co's PB Ratio falls into.



Andros Pharmaceuticals Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Andros Pharmaceuticals Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=20.95/10.522
=1.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Andros Pharmaceuticals Co  (ROCO:6917) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Andros Pharmaceuticals Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Andros Pharmaceuticals Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Andros Pharmaceuticals Co (ROCO:6917) Business Description

Traded in Other Exchanges
N/A
Address
No. 22, Sec. 2, Shengyi Road, 6th Floor, Building D, Biotech Building, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei City, TWN, 30261
Andros Pharmaceuticals Co Ltd is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The firm focuses on the development of topical new dosage forms and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy. Its product line comprises New Dosage Forms (Topical), Super Generics (Topical), High-End Cosmetic Ingredients (Topical), and Gene Delivery Systems (Injectable).

Andros Pharmaceuticals Co (ROCO:6917) Headlines

No Headlines